Clinical Trial Update: Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating total body irradiation with fludarabine-based conditioning followed by haploidentical transplantation for hematologic diseases. Results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma
• Leukemia
• Myelodysplastic Syndrome
• Non-hodgkin Lymphoma

Drugs mentioned

• Fludarabine (Fludarabine)

Snippet

Sponsor: Northside Hospital, Inc. | Conditions: Chronic Leukemia, Acute Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2016-01-14